Clinical Trial Detail

NCT ID NCT03840915
Title M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

non-small cell lung carcinoma

Therapies

Cisplatin + M7824 + Pemetrexed

Docetaxel + M7824

Carboplatin + M7824 + Pemetrexed

Cisplatin + Gemcitabine + M7824

Carboplatin + Gemcitabine + M7824

Carboplatin + M7824 + Nab-paclitaxel

Age Groups: adult senior

Additional content available in CKB BOOST